The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function …

M Steenbeke, S De Bruyne, M De Buyzere… - Critical Reviews in …, 2021 - Taylor & Francis
Isoforms of the receptor for advanced glycation end-product (RAGE) protein, which lack the
transmembrane and the signaling (soluble RAGE or sRAGE) domains are hypothesized to …

The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease

L Arivazhagan, CJ Popp, HH Ruiz… - Cardiovascular …, 2023 - academic.oup.com
Overweight and obesity are leading causes of cardiometabolic dysfunction. Despite
extensive investigation, the mechanisms mediating the increase in these conditions are yet …

Cross-sectional analysis of AGE-CML, sRAGE, and esRAGE with diabetes and cardiometabolic risk factors in a community-based cohort

SJ Loomis, Y Chen, DB Sacks, ES Christenson… - Clinical …, 2017 - academic.oup.com
BACKGROUND Advanced glycation end products (AGEs) and their receptors are regarded
as central to the development of diabetic complications, but associations with diabetes and …

Blood and tissue advanced glycation end products as determinants of cardiometabolic disorders focusing on human studies

Y Kim - Nutrients, 2023 - mdpi.com
Cardiometabolic disorders are characterised by a cluster of interactive risk determinants
such as increases in blood glucose, lipids and body weight, as well as elevated …

Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease

S Reichert, U Triebert, AN Santos, B Hofmann… - Atherosclerosis, 2017 - Elsevier
Background and aims Soluble RAGE (sRAGE) serum level could be a biomarker for
atherosclerosis and subsequent diseases such as cardiovascular disease (CVD). Therefore …

Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes

ER Miranda, VS Somal, JT Mey… - American Journal …, 2017 - journals.physiology.org
The soluble receptor for advanced glycation end products (sRAGE) may be protective
against inflammation associated with obesity and type 2 diabetes (T2DM). The aim of this …

[HTML][HTML] Endogenous secretory RAGE increases with improvements in body composition and is associated with markers of adipocyte health

ER Miranda, KNZ Fuller, RK Perkins… - Nutrition, Metabolism …, 2018 - Elsevier
Background and aims The receptor for advanced glycation end products (RAGE) is
implicated in obesogenesis. Conversely, soluble RAGE (sRAGE) competitively inhibits …

Obesity and comorbidity: could simultaneous targeting of esRAGE and sRAGE be the panacea?

C Eleazu, N Omar, OZ Lim, BS Yeoh… - Frontiers in …, 2019 - frontiersin.org
Obesity, a chronic multifaceted disease, predisposes its patients to increased risk of
metabolic disorders such as: diabetes mellitus, cardiovascular diseases, dyslipidemia, etc …

A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile

M Davarpanah, N Shokri-Mashhadi, R Ziaei… - Scientific reports, 2021 - nature.com
Several epidemiologic studies have evaluated the relation between serum/plasma brain-
derived neurotrophic factor (BDNF) levels and glycemic parameters, but the findings were …

Follicular fluid soluble receptor for advanced glycation endproducts (sRAGE): a potential protective role in polycystic ovary syndrome

BJ Wang, MM Hao, QL Yang, J Li, YH Guo - Journal of assisted …, 2016 - Springer
Purpose To explore the relationships between the soluble receptor for advanced glycation
endproducts (sRAGE) and the outcome parameters following in vitro fertilization-embryo …